Non-Whites Sorely Underrepresented in Phase 3 Psoriasis Trials
Medscape,
Non-White patient participation in phase 3 therapeutic trials for plaque psoriasis is less than 15%, according to a recently…
A Genetic Variant in the BCL2 Gene Associates with Adalimumab Response in Hidradenitis Suppurativa Clinical Trials and Regulates Expression of BCL2
Overview of attention for article published in Journal of Investigative Dermatology, August 2019
Altmetric Badge
About this Attention Score
-
In the top 25% of all research outputs scored by Altmetric
-
High Attention Score compared to outputs of the same age (83rd percentile)
-
High Attention Score compared to outputs of the same age and source (82nd percentile)
Readers on
- mendeley
- 43 Mendeley